100 related articles for article (PubMed ID: 2401310)
1. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
Karasawa A; Taylor PA; Lefer AM
Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310
[TBL] [Abstract][Full Text] [Related]
2. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Aoki N; Johnson G; Siegfried MR; Lefer AM
Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
Aoki N; Lefer AM
J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
Levitt MA; Stahl G; Lefer AM
Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
[TBL] [Abstract][Full Text] [Related]
7. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of two leukotriene antagonists in rat traumatic shock.
Levitt MA; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.
Shirakura S; Karasawa A; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1242-5. PubMed ID: 1815523
[TBL] [Abstract][Full Text] [Related]
10. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
Levitt MA; Lefer AM
Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Aoki N; Lefer AM
Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
Levitt MA; Lefer AM
Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
[TBL] [Abstract][Full Text] [Related]
15. Protective actions of aprotinin in acute traumatic shock.
Araki H; Lefer AM
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
Stahl GL; Bitterman H; Lefer AM
Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
Bitterman H; Stahl GL; Lefer AM
Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of a neutral protease inhibitor in traumatic shock.
Hock CE; Lefer AM
Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
